NCT00030862View on ClinicalTrials.gov

Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Esophagus

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

October 31, 2001

Primary Completion Date

December 31, 2003

Study Completion Date

December 31, 2003

Conditions
Esophageal Cancer
Interventions
DRUG

cisplatin

DRUG

irinotecan hydrochloride

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00030862 - Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Esophagus | Biotech Hunter | Biotech Hunter